SAB Biotherapeutics (SABS) Appoints Scott Giberson to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
| (NASDAQ: SABS) | Delayed: 2.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.84 | 52 Week High | $ | |||
| Open | $2.84 | 52 Week Low | $ | |||
| Day High | $2.84 | P/E | N/A | |||
| Day Low | $2.84 | EPS | $ | |||
| Volume | 2,943 | |||||
| (NASDAQ: SABSW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 2,943 | |||||
